Displaying 277 - 288 items out of 317 results

Press release

New Antibody-Drug Conjugate Shows Promising Efficacy in EGFR-Mutated NSCLC Patients

Press release

COMPEL Study Shows Continuing Osimertinib Treatment Through Progression with the Addition of Chemotherapy Improves Progression-Free Survival in EGFR-Mutated NSCLC

Press release

CheckMate 77T: Nivolumab Maintains Quality of Life and Reduces Symptom Deterioration in Resectable NSCLC

Press release

Study Validates AI Lung Cancer Risk Model Sybil in Predominantly Black Population at Urban Safety-Net Hospital

Press release

Iza-Bren in combination with Osimertinib Shows 100% Response Rate in EGFR-Mutated NSCLC, Phase II Study Finds

Press release

Ifinatamab Deruxtecan Demonstrates High Response Rate in Previously Treated Extensive-Stage Small Cell Lung Cancer: Phase 2 IDeate-Lung01 Trial

Press release

Ivonescimab Plus Chemotherapy Improves Progression-Free Survival in Patients with EGFR+ NSCLC Following 3rd-Generation EGFR-TKI Therapy

Press release

FLAURA2 Trial Shows Osimertinib Plus Chemotherapy Improves Overall Survival in EGFR-Mutated Advanced NSCLC

Press release

Aumolertinib Plus Chemotherapy Improves Progression-Free Survival in NSCLC with EGFR and Concomitant Tumor Suppressor Genes: ACROSS 2 Phase III Study

Press release

Crizotinib Fails to Improve Disease-Free Survival in Resected Early-Stage ALK+ NSCLC

Press release

First-in-Human Trial Shows Promising Results for DLL3-Targeted Antibody-Drug Conjugate SHR-4849 in Relapsed Small Cell Lung Cancer

Press release

Zidesamtinib Shows Durable Responses in ROS1 TKI Pre-treated NSCLC, Including Patients with CNS Disease and ROS1 G2032R Mutations